Sales · healthcare · Southern EuropeJul 20269 min read348 words

Founder-led sales for startups under 20 people for healthcare and life sciences in Southern Europe

How under-20-person startups get founder-led sales live without hiring — the specific version of the playbook designed for constraint. Written for commercial leaders at healthtech, medtech, and life-sciences companies in Southern Europe.

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Southern Europe. In this market, Southern European buyers reward relationship depth over transactional outreach, so the way you install founder-led sales has to be shaped to that reality from day one.

The under-20-person version of founder-led sales is not a diluted enterprise playbook. It is the founder personally running discovery, closing, and post-sale for the first 100 customers with different constraints: no headcount, no politics, and no time to be wrong for long.

Own it personally as a founder or lean-in operator for the first quarter. Hiring a specialist too early replaces context with process.

Pick one channel, one trigger, one message. Two of anything at this stage is too many and none of them will work.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Southern Europe it is compounded by the fact that relationship depth, not activity volume is what actually gates growth. Founder-led sales is only useful here when it is pointed at both constraints at once.

Instrument founder hours per week in customer conversations in a spreadsheet if you have to. Legibility beats sophistication under 20 people.

The startup-specific trap is hiring VP of Sales at $500k ARR to escape sales, usually because a well-meaning advisor points at what worked at their $50m company. Ignore.

Budget rules: whatever you spend on tools, spend the same on the person operating them. Under-tooling is fine; under-humaning is not.

A working founder-led sales function at 15 people is a genuine moat — most competitors of that size do not have one, and the discipline carries forward as the company grows.

Concretely for healthcare and life sciences in Southern Europe: the healthcare teams that install this get past procurement instead of dying in it, and a single trusted Southern European relationship compounds into a regional beachhead. That is the reason it is worth installing founder-led sales deliberately for this market rather than importing a playbook designed for somewhere else.

founder led salesfounder salesearly stage salesstartup founder led salesfounder led sales for early stagefounder led sales for healthcare and life sciencesfounder led sales in Southern Europehealthcare and life sciences growth in Southern Europe

Frequently asked questions

Sales · healthcare · Southern Europe — answered

Does founder-led sales work for healthcare and life sciences in Southern Europe?
Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in Southern Europe, Southern European buyers reward relationship depth over transactional outreach. The healthcare teams that install this get past procurement instead of dying in it.
Can a five-person team run founder-led sales?
Yes, if the founder owns it. The lower headcount, the more concentrated the ownership.
What is the smallest useful founder-led sales setup?
One channel, one trigger, one message, and a spreadsheet tracking founder hours per week in customer conversations.
Should we hire a specialist for founder-led sales?
Not in the first quarter. Own it personally until the model is proven.
What common advice should startups ignore?
Anything derived from a company more than 10x larger. Constraints differ.
What is the Southern Europe-specific pitfall when running founder-led sales for healthcare?
Importing a playbook that was built for another market. In Southern Europe, Southern European buyers reward relationship depth over transactional outreach — the install has to reflect that.

Growth Broker editorial

Filed under sales · healthcare · southern europe

Up next

AI for Growth: the complete 2026 guide for B2B companies

Read piece

Ready to broker your growth?

Book a Growth Call